Skip to main content
Clinical Trials/NCT06010251
NCT06010251RecruitingNot Applicable

Mechanisms and Utility of Multisensory Body- Representation in SCI and SCI-Related Neuropathic Pain

University of Miami2 sites in 1 country30 target enrollmentStarted: October 17, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
2
Primary Endpoint
Changes associated with sensory function/dysfunction assessed by quantitative sensory testing

Study Overview

Brief Summary

The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Changes associated with sensory function/dysfunction assessed by quantitative sensory testing

Time Frame: Baseline, up to 4 weeks

The sensory test assesses thermal thresholds and includes: cool detection threshold (CDT), warm detection threshold (WDT), cold pain threshold (CPT), hot pain threshold (HPT), all performed using the method of limits: 0 to 50 Celsius (ºC) all values will be reported in Celsius.

Change in neuropathic pain severity assessed by Neuropathic Pain Symptom Inventory (NPSI)

Time Frame: Baseline, up to 4 weeks

The NPSI is a self-reported, validated questionnaire that includes 10 items (on different pain sensations, e.g., burning, squeezing, electric-shock, etc.) used to evaluate the properties of neuropathic pain. Each item is scored on an 11-point NRS (0 meaning no symptom and 10 meaning worst symptom), with higher scores indicating more severe neuropathic pain symptoms.

Change in neuropathic pain interference assessed by pain interference questionnaire.

Time Frame: Baseline, up to 4 weeks

The questionnaire consists in a numerical rating of pain interference ranging from 0= No Interference to 10=Extreme interference with activities, mood and sleep

Secondary Outcomes

  • Changes of psychosocial assessed by Multidimensional Pain Inventory (pain severity subscale)(Baseline, up to 4 weeks)
  • Change in Global impression of changes by PGIC questionnaire(Baseline, up to 4 weeks)
  • Change in manageable pain assessed by days of manageable pain questionnaire.(Baseline, up to 4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Eva Widerstrom-Noga

Professor

University of Miami

Study Sites (2)

Loading locations...

Similar Trials